Do you want to read an article? Please log in or register.
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys
Hypertension
Related content
RECOMMENDED
Cardiovascular Risk and Diseases
Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Lancet Planet Health.
Hystad P, Larkin A, Rangarajan S, AlHabib KF, Avezum Á, Calik KBT, Chifamba J, Dans A, Diaz R, du Plessis JL, Gupta R, Iqbal R, Khatib R, Kelishadi R, Lanas F, Liu Z, Lopez-Jaramillo P, Nair S, Poirier P, Rahman O, Rosengren A, Swidan H, Tse LA, Wei L, Wielgosz A, Yeates K, Yusoff K, Zatoński T, Burnett R, Yusuf S, Brauer M
doi: 10.1016/S2542-5196(20)30103-0.
RECOMMENDED
Cardiovascular Risk and Diseases
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
doi: 10.1016/S0140-6736(20)30543-2.
Cardiovascular Risk and DiseasesLipid-Lowering Drugs
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
Lancet Diabetes Endocrinol.
Raal FJ, Hovingh GK, Blom D, Santos RD, Harada-Shiba M, Bruckert E, Couture P, Soran H, Watts GF, Kurtz C, Honarpour N, Tang L, Kasichayanula S, Wasserman SM, Stein EA
doi: 10.1016/S2213-8587
RECOMMENDED
Cardiovascular Risk and Diseases
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Lancet.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G
doi: 10.1016/S0140-
RECOMMENDED
HypertensionLipid-Lowering DrugsThrombosis and Stroke
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial
Lancet.
Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P
doi: 10.1016/S0140-
Hypertension
Variation in the Proportion of Adults in Need of BP-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1,037,215 Individuals from 50 Nationally Representative Surveys
Circulation
Sudharsanan N, Theilmann M, Kirschbaum TK, Manne-Goehler J, Azadnajafabad S, Bovet P, Chen S, Damasceno A, De Neve JW, Dorobantu M, Ebert C, Farzadfar F, Gathecha G, Gurung MS, Jamshidi K, Jørgensen JMA, Labadarios D, Lemp J, Lunet N, Mwangi JK, Saeedi Moghaddam S, Bahendeka SK, Zhumadilov Z, Bärnighausen T, Vollmer S, Atun R, Davies JI, Geldsetzer P
doi: 10.1161/CIRCULATIONAHA.120.051620
Cardiovascular Risk and Diseases
The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study
Lancet.
Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, Casanova A, Swaminathan S, Anjana RM, Kumar R, Rosengren A, Wei L, Yang W, Chuangshi W, Huaxing L, Nair S, Diaz R, Swidon H, Gupta R, Mohammadifard N, Lopez-Jaramillo P, Oguz A, Zatonska K, Seron P, Avezum A, Poirier P, Teo K, Yusuf S
doi: 10.1016/
Cardiac Arrest or Death
Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
Lancet
Syn NL, Cummings DE, Wang LZ, Lin DJ, Zhao JJ, Loh M, Koh ZJ, Chew CA, Loo YE, Tai BC, Kim G, So JB, Kaplan LM, Dixon JB, Shabbir A
doi: 10.1016/S0140-6736(21)00591-2
Hypertension
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
JAMA.
Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, Colantonio LD
doi: 10.1001/jama.